We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Vaccines Target Ticks, Not Disease

By Biotechdaily staff writers
Posted on 23 May 2002
Researchers are exploring the possibility of preventing tick-borne diseases by developing vaccines against the tick vector rather than against the pathogenic microorganisms that actually cause the disease. More...
Ticks harbor the causative agents for several serious diseases of animals and humans, including Lyme disease, Rocky Mountain spotted fever, Ehrlichiosis and relapsing fever. The research was described in a presentation given during the spring meeting of the Society for General Microbiology held at the University of Warwick (UK).

"A new solution to controlling tick-borne diseases is to develop vaccines against the ticks and not the microbes that cause the diseases. We have experimental vaccines containing molecules found on the tick's gut wall, which prevent the digestion of the blood meal and stop females from laying their eggs,” says Dr. Olivier Sparagano of Newcastle University (England).

So far it has been shown that the prototype vaccines reduce the fertility of female ticks and lessen the chances of survival of their larvae. Lowering the number of ticks will reduce the risk of animals and humans coming in contact with the disease-bearing arthropods. Dr. Sparagano warned that changes in climate are making Great Britain more suitable for ticks, and that incidence of tick-borne diseases are on the increase. He stressed that the import of ticks from southern Europe, Africa, and Asia should be prevented as far as possible while new methods for controlling the spread of tick-borne diseases are being developed.




Related Links:
Univ. of Newcastle upon Tyne

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.